Simbadol is a drug owned by ZOETIS INC. It is protected by 1 US drug patent filed in 2031. All patents are active. Details of Simbadol’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
Exclusivity Information
Simbadol holds 1 exclusivity out of which 1 has expired. Details of Simbadol's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCE | Jul 18, 2019 |
About Simbadol
Simbadol is a drug
owned by ZOETIS INC.
Simbadol uses
Buprenorphine as the active
ingredient.
Active Ingredient:
Simbadol uses
Buprenorphine as the active ingredient.
Check out other Drugs and Companies using
Buprenorphine ingredient.